Efficacy of Piezosurgery Versus Conventional Osteotomy in Prelacrimal Approach Targeting Different Maxillary Sinus Pathologies
prelacrimal
1 other identifier
interventional
40
1 country
1
Brief Summary
The prelacrimal recess approach is a minimally invasive approach to maxillary sinus lesions. The current study aimed to evaluate the efficacy of piezosurgery versus conventional osteotomy while performing a prelacrimal apporach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 30, 2025
CompletedFirst Posted
Study publicly available on registry
January 12, 2026
CompletedJanuary 12, 2026
December 1, 2025
12 months
December 30, 2025
December 30, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Intraoperative bleeding
The amount of blood collected in the suction device
During the surgical procedure
Operative time
the time of surgical procedure
During the surgical procedure
Secondary Outcomes (1)
Postoperative hyposthesia
six months after surgery
Study Arms (2)
piezosurgery group
ACTIVE COMPARATORconventional osteotomy group
ACTIVE COMPARATORInterventions
The removal of the bone in the prelacrimal approach was done using piezo ultrasonic device
The removal of the bone in the prelacrimal approach was done using conventional osteotome and hammer
Eligibility Criteria
You may qualify if:
- Any maxillary sinus pathology (recurrent Antrochoanal polyp, inverted papilloma, fungal ball, allergic fungal sinusitis, CRSwNP, CRSeNP, orbital floor fracture, etc).
- Favorable prelacrimal recess (Type II or III Simmen classification)
- Age\> 18 years.
- No gender limitation.
You may not qualify if:
- patients with malignant sino-nasal tumors.
- patients unfit for surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine, Mansoura University
Al Mansurah, Dakahlia Governorate, 35511, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2025
First Posted
January 12, 2026
Study Start
December 1, 2024
Primary Completion
November 30, 2025
Study Completion
November 30, 2025
Last Updated
January 12, 2026
Record last verified: 2025-12